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A new form of hypertension  
due to hyperaldosteronism
Grimm et al., Proc Natl Acad Sci USA 2009; 106: 11800–11805; 
doi:10.1073/pnas.0904635106
Large-conductance, voltage- and calcium (Ca)2+-sensitive 
potassium (K; BK) channels are very abundant in vascular 
smooth muscle cells (VSMCs). Upon activation (by changes 
in intracellular Ca2+ and membrane potential), they produce 
a K+ efflux, which hyperpolarizes the plasma membrane and 
thus diminishes VSMC contraction. It is currently believed 
that BK channels regulate the size of the lumen in blood 
vessels and contribute to blood pressure control. BK chan-
nels are composed of channel-forming BK-α and auxiliary 
BK-β1 subunits; mice with a disrupted BK-β1 subunit (gene, 
Kcnmb1; protein, BK-β1) were found to be mildly hyperten-
sive. In addition, gain-in-function mutations have been shown 
to confer protection against developing hypertension. How-
ever, BK channels are also found in the connecting tubules 
of the mammalian kidney, where they mediate K secretion 
in response to acute volume expansion. Because most forms 
of long-term hypertension involve renal excretory defects, 
Grimm et al. examined the pathogenesis of the hypertension 
in Kcnmb1−/− mice. They found that these mice had signifi-
cantly elevated plasma K and that their renal K clearance was 
decreased. Interestingly, the mice also had slightly elevated 
plasma sodium (and osmolality) and decreased renal sodium 
clearance. Kcnmb1−/− mice were volume expanded, especially 
when treated with a high-K diet (Figure). Of great interest is 
the authors’ finding that the plasma aldosterone was increased, 
and that most of the Kcnmb1−/− mice’s abnormalities were 
corrected upon treatment with eplerenone. This very interest-
ing study indicates that genetic ablation of BK-β1 results in 
a hyperaldosterone-hypertension syndrome that is exacer-
bated with a high-K diet. The increased aldosterone produc-
tion is due to elevated plasma K concentration resulting from 
diminished aldosterone-induced renal K secretion. Reevalu-
ation of patients with essential hypertension and elevated 
plasma aldosterone levels may be in order.
Juan Oliver
Comparing pulse and oral 
cyclophosphamide for remission  
in ANCA-associated vasculitis
De Groot et al., Ann Intern Med 2009; 150: 670–680
De Groot et al. examined whether pulsed intermittent cyclo-
phosphamide would be as effective but not as toxic as daily 
oral cyclophosphamide for the induction of remission in 
patients with generalized antineutrophil cytoplasmic antibody 
(ANCA)-associated vasculitis and active glomerulonephritis. 
The open-label, multicenter trial randomized subjects with 
newly diagnosed Wegener’s granulomatosis, microscopic poly-
angiitis, or renal-limited microscopic polyangiitis. The pulse 
cyclophosphamide group received three intravenous pulses of 
15 mg/kg given 2 weeks apart, followed by pulses at 3-week 
intervals of either 15 mg/kg intravenously or 5 mg/kg orally 
on 3 consecutive days until remission and then for another 3 
months. The daily cyclophosphamide group received 2 mg/kg 
per day orally until remission, followed by 1.5 mg/kg per day 
for another 3 months. Both groups had their doses reduced 
for advanced age and received their respective cyclophospha-
mide regimen for 3 months after remission, then 2 mg/kg 
azathioprine per day orally until month 18 of the study. Both 
groups also received 1 mg/kg prednisolone per day tapered 
to 12.5 mg at the end of month 3 and to 5 mg at month 18. No 
difference was found in time to remission or the number of 
subjects who achieved remission at 9 months. Although there 
were no differences in the numbers of subjects who relapsed, 
the authors caution that their study was underpowered. Five 
subjects in the pulse group and nine subjects in the daily oral 
group died (P = 0.79). Median estimated glomerular filtration 
rate (eGFR) was similar between groups throughout the study. 
Both groups experienced an improvement in median eGFR 
from the beginning to the end of the study. Subjects in the 
pulse group were less likely to be affected by leukopenia than 
those in the daily oral group. Of those who did experience an 
episode of leukopenia in the pulse group, the median time to 
first episode was longer, 219 days as compared with 68 days 
in the oral group. Although there was little difference in the 
number of episodes of infection, the median time to infection 
was longer in the pulse group, 147 days as compared with 68 
days in the daily oral group.
The number of centers, number of investigators, and genetic 
heterogeneity of subjects in this trial strongly support its appli-
cability to most populations. Despite the potential for an error 
with respect to a greater relapse rate in the pulse group, the 
success of induction was equivalent between groups. With that 
Extracellular volume expansion evaluated by hematocrit (Hct). As shown, 
Hct was lower in Kcnmb1−/− mice than in wild-type (WT) and was further 
reduced on a high-K diet. When the mice on a high-K diet (HK) were treated 
with eplerenone (E), the Hct values for WT and Kcnmb1−/− mice were not 
significantly different. The Hct values for the vehicle-treated group (V) were 
not different from those for the untreated mice on a high-K diet.
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caveat and equivalent remission rates, the advantages of pulse 
cyclophosphamide include a lower cumulative dose of cyclo-
phosphamide with fewer episodes of leukopenia.
Lynda Szczech
Essential role of TGF-β  
in hyperglycemia-induced 
hypertrophy
Wu and Derynck, Dev Cell 17: 35–48; doi:10.1016/j.devcel.2009.05.010
It is likely that high glucose can cause tissue damage by multi-
ple mechanisms. Interestingly, high glucose increases protein 
synthesis and cell size and promotes cell hypertrophy in many 
tissues and organs, including the kidney. Here, it also causes 
accumulation of extracellular matrix proteins and fibrosis. 
Cell size is tightly controlled and regulated by a pathway that 
is initiated when phosphatidylinositol 3-kinase (PI3K) phos-
phorylates Akt and that is activated by growth factors such as 
insulin and insulin-like growth factor-1. Hyperglycemia is well 
known to increase activation of transforming growth factor-β 
(TGF-β); in kidneys from diabetic animals, TGF-β1 levels were 
shown to increase and Smad3 was shown to become activated. 
However, it is unclear whether TGF-β sig naling is involved 
in the glucose-stimulated hypertrophy. TGF-β acts through 
cell-surface receptor complexes of two type I and two type II 
receptors: transforming β receptors I and II (TβRI and TβRII). 
Following ligand binding, the TβRIIs phosphorylate and acti-
vate the TβRIs, which activate Smad2 and Smad3; these then 
form a complex with Smad4, translocate into the nucleus, and 
regulate transcription of TGF-β-responsive genes. However, in 
cells undergoing epithelial-to-mesenchymal transition, it was 
recently found that TGF-β can activate PI3K. Accordingly, Wu 
and Derynck recently examined the role of TGF-β in hyperg-
lycemia-induced cell hypertrophy. They found in both fibrob-
lasts and epithelial cells that glucose-induced increase in cell 
size was blocked (Figure) by inhibition of the function of the 
TβRI kinase, thus blocking TGF-β signaling. Further, glucose 
induced a rapid externalization of the TβRII and TβRI recep-
tors at the cell surface as well as metalloproteinase-mediated 
TGF-β activation, thereby increasing autocrine TGF-β signaling. 
This in turn activated Akt and mediated high-glucose-induced 
cell hypertrophy. These important findings are relevant to our 
understanding of hyperglycemia-induced kidney hypertrophy 
and provide new research avenues in diabetic nephropathy.
Juan Oliver
CSF-1 mediates renal repair in mice
Menke et al., J Clin Invest 2009; 119: 2330–2342; doi:10.1172/JCI39087
Ischemic renal injury leads to tubular damage. This condition 
may be reversed, and proliferation of the tubular epithelial cell 
(TEC) is critical to this process. Macrophages have been found 
to participate in tissue repair; specifically, colony-stimulating fac-
tor-1 (CSF-1), the main macrophage growth factor, is expressed 
by TECs. Thus, deciphering the mechanisms by which CSF-1 
promotes renal healing and tubular repair may reveal new ther-
apeutic strategies for treating renal injury. Menke et al. tested 
the hypothesis that CSF-1 is central to tubular repair using the 
ischemia/reperfusion (I/R) acute renal injury and repair model. 
When mice were given CSF-1 following I/R, renal healing sped 
up, as shown by decreased tubular pathology, reduced fibro-
sis, and improved renal function (Figure). In particular, CSF-1 
increased TEC proliferation and reduced TEC apoptosis. Further, 
administration of a CSF-1 receptor (CSF-1R)-specific antibody 
after I/R increased tubular pathology and fibrosis, suppressed 
TEC proliferation, and increased TEC apoptosis. The authors 
then measured the effect of CSF-1 on I/R in mice in which 
CD11b+ cells were genetically ablated. Here, macrophages only 
partially contributed to CSF-1-dependent tubular repair. In addi-
tion, following renal injury in mice and humans, TECs expressed 
CSF-1R, which was upregulated and coexpressed with CSF-1, and 
signaling via the CSF-1R stimulated proliferation and reduced 
apoptosis in TECs. One can gather from these findings that 
CSF-1 mediates renal repair by both a macrophage-dependent 
mechanism and direct autocrine/paracrine action on TECs.
Marc De Broe
Renal tubular histopathology was more severe in CSF-1R Ab–injected than 
in control Ab (rat IgG)–injected mice. Representative photomicrographs 
and corresponding graphs indicate the number of dilated tubules and 
casts in the cortex and outer medulla. Ab, antibody.
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Cell-size distribution analysis showed that downregulation of 
transforming growth factor-β receptor I (TβRI) expression blocked the 
glucose-induced increase in cell size.
